• Search
      • Search Interactions Search Categories
    • Browse
      • Browse Categories Browse Sources
    • Information
      • About Publications Interaction Types & Directionalities Interaction Score & Query Score API Documentation FAQ Known Data Clients News Contact
    • Downloads
      • Data Source Code

SLC22A7 Gene Record

  • Summary
  • Interactions
  • Claims
  • SLC22A7 10864 Druggable Genome

    Alternate Names:

    10864
    SOLUTE CARRIER FAMILY 22 MEMBER 7
    SLC22A7
    NLT
    OAT2
    hOAT11
    604995
    10971
    ENSG00000137204
    OTTHUMG00000014726
    PA35848
    SOLUTE CARRIER FAMILY 22 MEMBER 7 ISOFORM B [SOURCE:REFSEQ_PEPTIDE;ACC:NP_696961]

    Gene Info:

    Human Readable Name DRUGGABLE GENOME
    Gene Biotype PROTEIN_CODING
    (1 More Sources)

    Gene Categories: Category Details

    DRUGGABLE GENOME

    Publications:

    Pellicer M et al., 2017, Identification of new SNPs associated with severe toxicity to capecitabine., Pharmacol Res
    Ghodke Y et al., 2012, PharmGKB summary: zidovudine pathway., Pharmacogenet Genomics
    Sheng XC et al., 2012, Discovery of GS-9256: a novel phosphinic acid derived inhibitor of the hepatitis C virus NS3/4A protease with potent clinical activity., Bioorg Med Chem Lett
  • GS-9256   SLC22A7

    Interaction Score: 13.74

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    22244938


    Sources:
    DTC

  • ZIDOVUDINE   SLC22A7

    Interaction Score: 1.33

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    22960662


    Sources:
    PharmGKB

  • CAPECITABINE   SLC22A7

    Interaction Score: 1.14

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    28347776


    Sources:
    PharmGKB

  • Ensembl: ENSG00000137204

    • Version: 101_38

    Alternate Names:
    SLC22A7 Ensembl Gene Name

    Gene Info:
    Gene Biotype PROTEIN_CODING

    Publications:

  • RussLampel: ENSG00000137204

    • Version: 26-July-2011

    Alternate Names:
    SOLUTE CARRIER FAMILY 22 MEMBER 7 ISOFORM B [SOURCE:REFSEQ_PEPTIDE;ACC:NP_696961] Description
    SLC22A7 Display Id
    ENSG00000137204 Ensembl Gene Id

    Gene Info:
    Human Readable Name DRUGGABLE GENOME

    Gene Categories:
    DRUGGABLE GENOME

    Publications:

  • PharmGKB: SLC22A7

    • Version: 18-August-2020

    Alternate Names:
    PA35848 PharmGKB ID

    Gene Info:

    Publications:
    Ghodke Y et al., 2012, PharmGKB summary: zidovudine pathway., Pharmacogenet Genomics
    Pellicer M et al., 2017, Identification of new SNPs associated with severe toxicity to capecitabine., Pharmacol Res

  • DTC: SLC22A7

    • Version: 02-September-2020

    Alternate Names:

    Gene Info:

    Publications:
    Sheng XC et al., 2012, Discovery of GS-9256: a novel phosphinic acid derived inhibitor of the hepatitis C virus NS3/4A protease with potent clinical activity., Bioorg Med Chem Lett

  • HingoraniCasas: ENSG00000137204

    • Version: 31-May-2017

    Alternate Names:
    ENSG00000137204 Gene Symbol
    SLC22A7 Ensembl Id

    Gene Info:

    Gene Categories:
    DRUGGABLE GENOME

    Publications:

Disclaimer: This resource is intended for purely research purposes. It should not be used for emergencies or medical or professional advice.

A finding of a drug-gene interaction or potentially druggable category does not necessarily indicate effectiveness (or lack thereof) of any drug or treatment regimen. A finding of no interaction or no potentially druggable category does not necessarily indicate lack of effectiveness of any drug or treatment regimen. Drug-gene interactions or potentially druggable categories are not presented in ranked order of potential or predicted efficacy.

The dgidb.org website does not provide any medical or healthcare products, services or advice, and is not for medical emergencies or urgent situations. IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR OR 911 IMMEDIATELY. Information contained on this website is not a substitute for a doctor's medical judgment or advice. We recommend that you discuss your specific, individual health concerns with your doctor or health care professional.

DGIdb (v4.2.0 - sha1 afd9f30b) • Last updated 2020-10-21